Enzo Biochem Inc. | Balance Sheet

Fiscal year is August-July. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
9,007.00
17,455.00
18,109.00
67,777.00
64,167.00
60,041
Total Accounts Receivable
12,288.00
12,470.00
18,759.00
14,592.00
15,180.00
13,147
Inventories
8,805.00
8,690.00
7,396.00
6,971.00
7,047.00
7,278
Other Current Assets
2,456.00
2,121.00
2,222.00
2,057.00
2,690.00
2,734
Total Current Assets
32,556.00
40,736.00
46,486.00
91,397.00
89,084.00
83,200
Net Property, Plant & Equipment
8,617.00
7,730.00
7,948.00
8,214.00
7,901.00
7,636
Intangible Assets
17,395.00
15,560.00
13,607.00
11,874.00
10,347.00
9,338
Other Assets
390.00
385.00
353.00
336.00
333.00
1,486
Total Assets
58,958.00
64,411.00
68,394.00
111,821.00
107,665.00
101,660
ST Debt & Current Portion LT Debt
3,595.00
3,403.00
3,013.00
2,100.00
331.00
Accounts Payable
8,481.00
8,245.00
8,762.00
9,857.00
10,350.00
Other Current Liabilities
11,776.00
13,317.00
12,183.00
8,611.00
7,129.00
Total Current Liabilities
23,852.00
24,965.00
23,958.00
20,568.00
17,810.00
Long-Term Debt
774.00
713.00
573.00
899.00
573.00
Provision for Risks & Charges
-
-
-
800.00
410.00
Deferred Taxes
200.00
183.00
37.00
-
-
Other Liabilities
-
1,600.00
1,220.00
-
-
Total Liabilities
24,826.00
27,461.00
25,788.00
22,267.00
18,793.00
Common Equity (Total)
34,132.00
36,950.00
42,606.00
89,554.00
88,872.00
Total Shareholders' Equity
34,132.00
36,950.00
42,606.00
89,554.00
88,872.00
Total Equity
34,132.00
36,950.00
42,606.00
89,554.00
88,872.00
Liabilities & Shareholders' Equity
58,958.00
64,411.00
68,394.00
111,821.00
107,665.00

About Enzo Biochem

View Profile
Address
60 Executive Boulevard
New York New York 11735
United States
Employees -
Website http://www.enzo.com
Updated 07/08/2019
Enzo Biochem, Inc. engages in the research, development, and market of pharmaceutical products. Its medicines target the following conditions: inflammatory bowel disease, uveitis, human immunodeficiency virus, diabetes, and bone disorders. The company was founded by Elazar Rabbani, Barry W.